Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
29.54
-0.38 (-1.27%)
At close: Aug 10, 2026, 4:00 PM EDT
29.50
-0.04 (-0.14%)
After-hours: Aug 10, 2026, 7:56 PM EDT
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.82 billion as of August 10, 2026. Its market cap has increased by 40,513.72% in one year.
Market Cap
1.82B
Enterprise Value
1.28B
1-Year Change
40,513.72%
Ranking
Category
Stock Price
$29.54
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.82B, an increase of 393.05%. That is a compound annual growth rate of 31.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 1.82B | 4,847.12% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Generate Biomedicines | 1.89B |
| Kardigan | 1.88B |
| Forte Biosciences | 1.88B |
| Bicara Therapeutics | 1.82B |
| Syndax Pharmaceuticals | 1.82B |
| Sarepta Therapeutics | 1.81B |
| Fortrea Holdings | 1.81B |
| Lakefront Biotherapeutics NV | 1.78B |